Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
needle-free drug delivery
Pharma
Vaxxas raises $23M to fund needle-free COVID-19 vaccine trial
Vaxxas has secured funding to support clinical development of its needle-free COVID-19 vaccine, stuffing its coffers with $23 million from investors.
Nick Paul Taylor
Dec 6, 2022 10:25am
PharmaJet partners to use needle-free tech in polio vaccine push
Nov 15, 2022 8:50am
Gerresheimer invests in Portal's needle-free drug delivery
May 9, 2022 3:00am
Scancell taps PharmaJet for needle-free COVID-19 vaccine study
Sep 21, 2021 9:30am
Beating Botox: Merz and Vensica team up for needleless delivery
Aug 17, 2021 8:15am